The ‘plastic spoon' of microplastics in your brain could stem from these foods that are wrecking your health, researchers say
Earlier this year, scientists discovered that there is about as much microplastics in the brain as a whole plastic spoon. The paper, published in Nature Medicine in February, revealed that the amount of microplastics—tiny plastic particles smaller than 5 millimeters—in the human brain appears to be increasing: Concentrations rose by about 50% between 2016 and 2024.
Not only were there more microplastics in the brain than in liver or kidney tissue, but microplastic concentrations were higher in the brains of dementia patients than in those without it.
Now, scientists are examining the effect on brain health of microplastics and one of the largest sources of microplastics: ultra-processed foods (UPFs). In a series of four papers published in the journal Brain Medicine, researchers synthesize mounting evidence that microplastics accumulating in the brain—especially those from UPFs—could be contributing to rising global rates of dementia, depression, and other mental health disorders.
'We're seeing converging evidence that should concern us all,' said co-author of one of the papers, Dr. Nicholas Fabiano from the University of Ottawa, in the press release.
'Ultra-processed foods now comprise more than 50% of energy intake in countries like the United States, and these foods contain significantly higher concentrations of microplastics than whole foods,' Fabiano said. 'Recent findings show these particles can cross the blood-brain barrier and accumulate in alarming quantities.'
The researchers consolidate the science linking UPF consumption with adverse mental health, and how that overlaps with microplastic accumulation in the brain. For instance, they cite a 2024 umbrella review published in the British Medical Journal which found that people who consumed ultra-processed foods had a 22% higher risk of depression, 48% higher risk of anxiety, and 41% higher risk of poor sleep.
In the papers, the researchers hypothesize that microplastics could be the missing link in UPFs' impact on brain health, by connecting it to data such as UPFs like chicken nuggets contain 30 times more microplastics per gram than chicken breasts—highlighting how processing could increase microplastic content.
'Ultra-processed foods have been linked to adverse mental health through inflammation, oxidative stress, epigenetics, mitochondrial dysfunction, and disruptions to neurotransmitter systems. Microplastics appear to operate through remarkably similar pathways,' said Wolfgang Marx from Deakin University's Food & Mood Center in Australia.
Microplastics can increase inflammation in the brain as they cross the blood-brain barrier, as a 2023 study on mice found, which can put people at risk of neurological disease and degeneration, including Alzheimer's.
'What emerges from this work is not a warning. It is a reckoning,' wrote Dr. Ma-Li Wong, professor of neuroscience at Upstate Medical University in New York. 'The boundary between internal and external has failed. If microplastics cross the blood-brain barrier, what else do we think remains sacred?'
Researchers are now looking to understand to what extent ultra-processed foods are responsible for adverse brain health outcomes, and what to do about it. The authors propose the development of a Dietary Microplastic Index, which would quantify people's exposure through food consumption.
'While we need to reduce our exposure to microplastics through better food choices and packaging alternatives, we also need research into how to remove these particles from the human body,' noted Dr. Stefan Bornstein in his paper. One of those potential methods, Bornstein proposes, is apheresis, a process of removing blood from the body and filtering out the microplastics—but he points out that more research is still needed.
'As the levels of ultra-processed foods, microplastics, and adverse mental health outcomes simultaneously rise, it is imperative that we further investigate this potential association,' said Fabiano. 'After all, you are what you eat.'
For more on microplastics:
Microplastics are everywhere. Here are 5 ways to reduce your exposure
Chewing gum is shedding harmful microplastics into your saliva, study finds
Tea bags and these 11 foods are likely exposing you to billions of microplastics
This story was originally featured on Fortune.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Sleep disorders increase dementia risk
People who experience sleep disorders are at greater risk of developing neurodegenerative conditions, including dementia, new research has found. The study, conducted by researchers at Cardiff University, found that diagnoses of sleep disorder made people up to twice as likely to develop a neurodegenerative disease in the 15 years that followed. The peer-reviewed study used data from more than a million electronic health records. "This increased risk was occurring independently of genetic risk factors for Alzheimer's and Parkinson's, with sleep disorders almost 'compensating' for low genetic risk," said Prof Valentina Escott-Price, from the UK Dementia Research Institute at Cardiff University. Call for danger warnings to rugby parents over dementia fears I love dad to bits - but being his carer has broken me The researchers examined data from three biobanks – facilities that store biological samples and are used for health research – from which they were "able to obtain accurate, timestamped records of when people experienced sleep disorders". The team analysed those who had been diagnosed with one of more sleep disorder, grouping them into those associated with "circadian rhythm" – or body clock – such as sleepwalking and narcolepsy, and "non-organic" sleep disorders not linked to a known psychological condition, including generalised insomnia and nightmares. The key findings were: Circadian sleep disorders and non-organic sleep disorders were associated with an increased risk of dementia in the 10 to 15 years that followed. The risk was further increased for those with multiple sleep disorders. Circadian sleep disorders increased the risk of Alzheimer's in the 10 to 15 years following sleep disorder diagnosis. Circadian sleep disorders and non-organic sleep disorders increased the risk of vascular dementia in the 5 to 10 years following sleep disorder diagnosis. The risk was further increased for those with multiple sleep disorders. Circadian sleep disorders and non-organic sleep disorders increased risk of Parkinson's in the 10 to 15 years following sleep disorder diagnosis. Dr Emily Simmonds, bioinformatician at the UK Dementia Research Institute at Cardiff University, said the study aimed to "understand the complicated relationship between sleep and dementia". She said: "People living with dementia often experience sleep problems, but there is not yet enough evidence to say for sure whether poor sleep increases risk of dementia. "Our results are compelling, indicating a clear increased risk of neurodegenerative disease following a sleep disorder." Prof Escott-Price, also from Cardiff University, said that while further investigation is needed the research "points towards sleep disorders as a risk factor for these conditions". Future research will examine whether improving sleep through the use of medication leads to a reduction in risk.
Yahoo
an hour ago
- Yahoo
This Popular Supplement May Help With Alzheimer's Symptoms
Creatine is everywhere on social media right now, with recs coming from influencers and health experts. Research is starting to find that the popular supplement can do more than help you build muscle. In a small pilot trial published in a journal, researchers found that creatine monohydrate may help improve cognitive function in individuals with Alzheimer's Disease. It's hard to cruise your For You feed right now without being faced with yet another testimonial about the perks of taking a creatine supplement. While creatine is the supplement du jour, there is solid data to support its use—mostly around fitness. But a growing body of research suggests that creatine may do more than help you build muscles, including easing depression and helping with brain fog after a bad night's sleep. Now, a new study suggests that there may be some benefit to using creatine to boost cognition in people with Alzheimer's disease. The research is very early and this is technically a pilot trial (which is basically a trial run). But the findings bring up a number of questions about whether something as simple as adding a creatine supplement could help improve symptoms in people with such a devastating condition. Here's what the study, found plus what doctors and nutritionists recommend keeping in mind. Meet the experts: Amit Sachdev, MD, is the medical director in the Department of Neurology at Michigan State University; Albert Matheny, RD, CSCS, is co-founder of SoHo Strength Lab; Matthew Taylor, PhD, RD, is a study co-author, assistant professor, and director of the KU Brain Nutrition Laboratory at University of Kansas Medical Center; Clifford Segil, DO, is a neurologist at Providence Saint John's Health Center in Santa Monica, CA The study, which was published in the journal Alzheimer's & Dementia Translational Research & Clinical Interventions, looked into the 'feasibility' of patients with Alzheimer's disease taking 20 grams a day of creatine monohydrate (the most widely studied form of creatine) for eight weeks. The researchers looked at how compliant the patients were (i.e. how likely they were to take the supplement). They also monitored levels of creatine in the patients' blood at the start, four weeks, and eight weeks later, along with levels of creatine in their brains. They also tested the patients' cognition at the start of the study and after eight weeks. The researchers found that 19 of the 20 participants were more than 80 percent compliant with taking the creatine during the study. They also found that creatine levels went up in their blood after four and eight weeks, and that creatine in the brain increased by 11 percent. And here's the really interesting part: The researchers discovered that the patients had better improvements in cognitive tests, including sorting and reading, along with tests to measure attention and response, after eight weeks of creatine supplementation. The researchers concluded that the findings provide 'preliminary evidence' for more research. 'We decided to do this study because there were a couple of recent studies in mice suggesting that, in a mouse model of Alzheimer's, creatine monohydrate supplementation may be beneficial,' says study co-author Matthew Taylor, PhD, RD, assistant professor and director of the KU Brain Nutrition Laboratory at University of Kansas Medical Center. 'Prior to this study, no work had been done in humans with Alzheimer's, so it was the right time to start looking at it as a potentially beneficial supplement for Alzheimer's.' The study didn't look into this, but there are some theories. 'The brain requires a lot of energy, but in Alzheimer's, brain energy metabolism drastically declines,' Taylor explains. 'Creatine is a very important substance for transporting energy produced by our mitochondria and increasing creatine levels may even encourage mitochondria to produce more energy.' Albert Matheny, RD, CSCS, co-founder of SoHo Strength Lab, co-signs that theory. Creatine helps to produce adenosine triphosphate (ATP), 'and ATP is the brain's primary energy source,' he says. Adding more creatine to the body could, in theory, help support cognition in people with Alzheimer's disease, Matheny adds. Creatine may also have other roles, like decreasing inflammation and oxidative stress in the body, which could potentially help with symptoms of Alzheimer's disease, Taylor says. 'Each of these roles could help with cognitive function in Alzheimer's, but we still have so much to learn about the roles of this molecule in the brain,' he says. We're not there yet. Again, this was a pilot study and it simply found that people who have Alzheimer's disease may be able to regularly take creatine supplements and might have a boost in cognition as a result. But this doesn't mean that people with Alzheimer's disease should take creatine, says Amit Sachdev, MD, medical director in the Department of Neurology at Michigan State University. 'I would not advise the use of creatine with the goal of improving cognition,' he says, noting that there's not yet 'well-established data to support this use.' Clifford Segil, DO, a neurologist at Providence Saint John's Health Center in Santa Monica, CA, agrees. "We are not at a point that creatine supplementation for brain health is an accepted supplement," he says. Taylor agrees. 'Our study is far from a definitive study,' he says. 'Well-designed, placebo-controlled clinical trials are needed to determine whether creatine is beneficial for Alzheimer's. I would suggest Alzheimer's patients and their families discuss taking any supplement with their neurologist.' You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Yahoo
4 hours ago
- Yahoo
Sleep disorders increase dementia risk
People who experience sleep disorders are at greater risk of developing neurodegenerative conditions, including dementia, new research has found. The study, conducted by researchers at Cardiff University, found that diagnoses of sleep disorder made people up to twice as likely to develop a neurodegenerative disease in the 15 years that followed. The peer-reviewed study used data from more than a million electronic health records. "This increased risk was occurring independently of genetic risk factors for Alzheimer's and Parkinson's, with sleep disorders almost 'compensating' for low genetic risk," said Prof Valentina Escott-Price, from the UK Dementia Research Institute at Cardiff University. Call for danger warnings to rugby parents over dementia fears I love dad to bits - but being his carer has broken me The researchers examined data from three biobanks – facilities that store biological samples and are used for health research – from which they were "able to obtain accurate, timestamped records of when people experienced sleep disorders". The team analysed those who had been diagnosed with one of more sleep disorder, grouping them into those associated with "circadian rhythm" – or body clock – such as sleepwalking and narcolepsy, and "non-organic" sleep disorders not linked to a known psychological condition, including generalised insomnia and nightmares. The key findings were: Circadian sleep disorders and non-organic sleep disorders were associated with an increased risk of dementia in the 10 to 15 years that followed. The risk was further increased for those with multiple sleep disorders. Circadian sleep disorders increased the risk of Alzheimer's in the 10 to 15 years following sleep disorder diagnosis. Circadian sleep disorders and non-organic sleep disorders increased the risk of vascular dementia in the 5 to 10 years following sleep disorder diagnosis. The risk was further increased for those with multiple sleep disorders. Circadian sleep disorders and non-organic sleep disorders increased risk of Parkinson's in the 10 to 15 years following sleep disorder diagnosis. Dr Emily Simmonds, bioinformatician at the UK Dementia Research Institute at Cardiff University, said the study aimed to "understand the complicated relationship between sleep and dementia". She said: "People living with dementia often experience sleep problems, but there is not yet enough evidence to say for sure whether poor sleep increases risk of dementia. "Our results are compelling, indicating a clear increased risk of neurodegenerative disease following a sleep disorder." Prof Escott-Price, also from Cardiff University, said that while further investigation is needed the research "points towards sleep disorders as a risk factor for these conditions". Future research will examine whether improving sleep through the use of medication leads to a reduction in risk.
